Grace Therapeutics, Inc. - GRCE
Ownership (Schedule 13D / 13G) · latest 50 filings
· Back to all files
Visible: 0
| Filed | Form | Reporting person | Percent | Shares | SEC |
|---|---|---|---|---|---|
| Aug 14, 2026 | SCHEDULE 13G/A | ADAR1 Capital Management, LLC | 9.9% | 1,806,216 | View |
| Aug 14, 2026 | SCHEDULE 13G/A | ADAR1 Capital Management GP, LLC | 8.6% | 1,525,757 | View |
| Aug 14, 2026 | SCHEDULE 13G/A | Daniel Schneeberger | 9.9% | 1,806,216 | View |
| Aug 14, 2026 | SCHEDULE 13G/A | Nantahala Capital Management, LLC | 6.75% | 1,178,203 | View |
| Aug 14, 2026 | SCHEDULE 13G/A | Wilmot B. Harkey | 6.75% | 1,178,203 | View |
| Aug 14, 2026 | SCHEDULE 13G/A | Daniel Mack | 6.75% | 1,178,203 | View |
| Aug 07, 2026 | SCHEDULE 13G | Opaleye Management Inc. | 13.07% | 2,748,392 | View |
| Aug 07, 2026 | SCHEDULE 13G | Opaleye, L.P. | 13.07% | 2,748,392 | View |
| Aug 07, 2026 | SCHEDULE 13G | James Silverman | 13.07% | 2,748,392 | View |
| May 15, 2026 | SCHEDULE 13G/A | ADAR1 Capital Management, LLC | 9.9% | 1,717,009 | View |
| May 15, 2026 | SCHEDULE 13G/A | ADAR1 Capital Management GP, LLC | 9.9% | 1,717,426 | View |
| May 15, 2026 | SCHEDULE 13G/A | Daniel Schneeberger | 9.9% | 1,717,009 | View |
| Apr 27, 2026 | SCHEDULE 13G/A | Orin Hirschman | 4.9% | 814,000 | View |
| Apr 27, 2026 | SCHEDULE 13G/A | AIGH Capital Management LLC | 4.9% | 814,000 | View |
Percent = "% of class represented by amount beneficially owned" for this reporting person in the filed 13D/13G.
Shares = reported beneficial ownership amount for the same row (not portfolio shares from 13F).
Amendments (/A) can repeat the same holder over time, so rows should not be summed.
Extraction is best-effort from filing text and can be missing or noisy; verify exact figures via the SEC link in each row.